Results 131 to 140 of about 3,848,281 (310)

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Try “Time Warp Challenge” to track progress on long‐term goals [PDF]

openalex   +1 more source

Effect of <i>Piper betle</i> extract on anti-candidal activity, gelation time, and surface hardness of a short-term soft lining material

, 2020
Juthatip KUMPANICH, Trinuch Eiampongpaiboon, Widchaya Kanchanavasita, Somsak Chitmongkolsuk, Jindaporn Puripattanavong   +4 more
openalex   +2 more sources

Short-Term Streamflow Forecasting Using Hybrid Deep Learning Model Based on Grey Wolf Algorithm for Hydrological Time Series [PDF]

, 2022
Hüseyin Çağan Kılınç, Adem Yurtsever   +1 more
openalex   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Identification of an unknown source term for a time fractional fourth-order parabolic equation

Electronic Journal of Differential Equations, 2016
In this article, we considered two inverse source problems for fourth-order parabolic differential equation with fractional derivative in time. Determination of a space dependent source term from the data given at some time t=T is considered in one ...
Sara Aziz, Salman A. Malik
doaj  

Long-term in situ measurements of NO _x and NO _y at Jungfraujoch 1998–2009: time series analysis and evaluation

, 2011
S. Pandey Deolal, Dominik Brunner, Martin Steinbacher, U. Weers, J. Staehelin   +4 more
openalex   +1 more source

Time estimation and concurrent nontemporal processing: Specific interference from short-term-memory demands [PDF]

, 1993
C. Fortin, R. J. ROUSSEAU, Pierre‐André Bourque, Éric Kirouac   +3 more
openalex   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source